COST PLUS FIXED FEENO SET ASIDE USED.

CRESTONE, INC. - TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.

PIID: 75N93020C00020Solicitation ID: HHS-NIH-NIAID-BAA2019-1

Signed Date: Jan 7, 2026Effective Date: Jul 1, 2020End Date: Closed on Aug 19, 2026

Award $

$20.5M

Vendor

CRESTONE, INC.

NAICS

541715

Signed Date

Jan 7, 2026

Key Details

Dollars Obligated

$20.5M

Base & All Options

$2.0M

Awarding Agency

Awarding Sub-Agency

National Institutes of Health

NAICS Code

Product Service Code

AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Number of Offers

Place of Performance

BOULDER, CO, 803013203, CD-CO-02

TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.

On Jan 7, 2026, Department of Health and Human Services obligated $20,477,990 to CRESTONE, INC. for to advance a promising, small-molecule compound crs0540 to ind filing and through phase i clinical studies.. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition with 12 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in BOULDER, CO.